A voxel-based morphometry study of temporal lobe gray matter reductions in Alzheimer’s disease
Introduction
Alzheimer’s disease (AD) is a neurodegenerative disorder characterized by progressive cognitive decline and a wide range of behavioral disturbances. The disease is associated with an uneven and progressive loss of neurons, with the presence of amyloid-containing neuritic plaques and neurofibrillary tangles. These changes are particularly marked in medial temporal lobe structures, including the hippocampus and parahippocampal gyrus [1], [10]. These structures are critical for episodic memory processes and, as a consequence, AD pathology consistently produces deficits in this memory domain as its earliest clinical manifestation [55]. As the disease progresses, AD pathology spreads to other regions throughout the brain, including lateral portions of the temporal lobe that are relevant to language processes, which are also commonly impaired in AD [28].
Numerous studies have described medial temporal lobe atrophy in AD patients by performing quantitative volumetric measurements using structural magnetic resonance imaging (MRI) [8], [9], [17], [33], [37], [44], [45]. Volume measurements of medial temporal structures have been proposed as useful to aid clinicians in their diagnostic work up, with an accuracy to differentiate AD patients from age-matched healthy controls ranging from 85 to 100% among different studies [9], [33], [34], [36], [37], [38], [50]. Medial temporal volumes have also been found to correlate with the degree of memory impairment of AD patients in some MRI studies [9], [38], [47], even though others failed to replicate these findings [37], [45], [46]. Although with lesser power to discriminate between AD patients and healthy controls, reductions in lateral temporal lobe volumes have also been described in AD [32], [36], [45], [46]; in some studies, these atrophic findings were directly correlated with the severity of language and memory deficits [45], [46].
Most MRI studies to date have quantified volumetric abnormalities in AD by drawing regions-of-interest (ROIs) as irregular shapes around selected brain regions. Some studies took measures from a combination of medial temporal structures [45], while others separately measured distinct portions of the hippocampus, parahippocampal gyrus [8], [11], [17], [33], [34], [37], [61], and amygdala [11], [33], [36], [37]. Methods for delineating ROIs are labor intensive and subject to observer bias, and variable anatomical borders have been used across different studies. In regard to lateral temporal structures, volumes have been most often obtained with large ROIs [31], [32], [36], [45], rather than with separate measurements for specific gyri [12]. As a consequence, it is unclear whether the reported atrophic findings of the lateral temporal lobe represent an overall homogeneous change ore are confined to smaller, circumscribed sites.
Recently, automated methods have been developed to allow voxel-by-voxel comparisons of the local concentration of gray matter between different groups of subjects studied with MRI, without requiring the a priori selection of ROIs [2], [27]. This technique, referred to as voxel-based morphometry (VBM), is based on the statistical parametric mapping (SPM) method often employed for voxel-based analyses of functional imaging data. Structural MRI scans are subjected to spatial transformations into a standard stereotactic space in order to remove inter-individual variations in brain size and shape, and are subsequently segmented into gray and white matter compartments. Gray matter segments are then compared statistically between groups on a voxel-by-voxel basis, and statistical maps are produced in standardized brain space showing the location of voxel clusters where significant differences in mean gray matter volumes were detected.
The VBM approach has been increasingly used to investigate gray matter abnormalities in neuropsychiatric conditions such as schizophrenia [53], [60], depression [51], infectious organic disorders [25], and dementia [5], [43], [48]. In the first assessment of AD using the VBM approach, seven AD patients were compared to seven healthy controls with the purpose of investigating gray matter abnormalities over the entire cerebral volume in an unbiased fashion [48]. In addition to the expected bilateral atrophic changes in the medial temporal region, the authors found symmetric gray matter reductions in other brain regions not usually included in ROI-based morphometric studies of AD, such as the caudate nucleus and the insula [48]. More recently, a larger VBM study also detected multifocal gray matter reductions in mild AD patients relative to healthy controls, involving medial temporal structures and other brain regions, particularly the posterior cingulate gyrus and the precuneus [5].
In the present study, we used the VBM approach to conduct a more detailed assessment of the temporal lobe in a sample of probable AD patients (n=14) in comparison to healthy controls (n=14). Gray matter changes were investigated over the entire extension of the temporal lobe, rather than on selected portions of this brain region as in previous ROI-based studies. Our aims were: to replicate previous MRI findings of reduced volumes in medial temporal structures; and to assess the topographic distribution of gray matter changes across the separate gyri of the lateral temporal cortex.
Section snippets
Study population and clinical assessment
Fourteen patients with AD were recruited from two specialized outpatient psychogeriatric units in the city of São Paulo, Brazil (Departments of Psychiatry of the University of São Paulo and Santa Casa Medical School)—they all met NINDS/ADRDA criteria for probable AD [39]. Study participants were interviewed with the Cambridge Mental Disorders of the Elderly Examination (CAMDEX) [49]. In addition, their assessment included full blood count; liver, renal and thyroid function tests; Vitamin B12
Results
The sum of intensity values of all voxels in the brain obtained from the segmented gray matter images had a mean value of 92,644.29 (S.D.=6.979.35) in the AD group, and 97,696.43 (S.D.=4.354.01) in the healthy control group (t=−2.30, d.f.=26, P=0.030). This indicated the presence of overall gray matter reductions in the brains of AD patients relative to healthy controls. The statistical parametric map investigating the regional location of reductions in gray matter volume in the AD group
Discussion
This structural MRI study investigated gray matter reductions in AD patients relative to healthy controls using the VBM approach. As predicted, significant gray matter decrements were detected bilaterally in the medial temporal region. This is consistent with the results of many previous ROI-based morphometric studies that reported atrophic changes in AD patients relative to controls in several medial temporal structures, measured either separately or in combination [8], [11], [15], [17], [34],
Acknowledgements
We thank Mrs. Celia M.D. Cheda for assistance with clinical data collection, Ms. Keila M. Nunes for technical support in the image analysis, and Dr. Wilson Jacob Filho for granting us access to elderly subjects included in the study. This study was supported by grants from the Fundação de Amparo à Pesquisa do Estado de São Paulo, Brazil (95/9446-1, 99/09547-3 and 99/12205-7).
References (61)
- et al.
Voxel-based morphometry—the methods
Neuroimage
(2000) - et al.
In vivo mapping of gray matter loss with voxel-based morphometry in mild Alzheimer’s disease
Neuroimage
(2001) - et al.
MRI of entorhinal cortex in mild Alzheimer’s disease
Lancet
(1999) - et al.
Atrophy of the medial occipitotemporal, inferior, and middle temporal gyri in non-demented elderly predict decline to Alzheimer’s disease
Neurobiol. Aging
(2000) - et al.
Specific hippocampal volume reductions in individuals at risk for Alzheimer’s disease
Neurobiol. Aging
(1997) - et al.
Phonological and articulatory impairment in Alzheimer’s disease: a case series
Brain Lang.
(2000) - et al.
MRI-derived entorhinal and hippocampal atrophy in incipient and very mild Alzheimer’s disease
Neurobiol. Aging
(2001) - et al.
Topography of brain atrophy during normal aging and Alzheimer’s disease
Neurobiol. Aging
(1996) - et al.
Mini-mental state. A practical method for grading the cognitive state of patients for the clinician
J. Psychiatr. Res.
(1975) - et al.
Visualisation and quantification of rates of atrophy in Alzheimer’s disease
Lancet
(1996)